Furthermore, these bacteria are involved in cholesterol transport and fatty acid metabolism and can down-regulate the expression of sterol regulatory element binding protein-1c (SREBP-1c), thereby ameliorating NAFLD (Han et al., 2022). This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.